Nathanael Fillmore PhD
Adjunct Assistant Professor, Hematology & Medical Oncology
820 Harrison Ave | (617) 638-7012nf@bu.edu
Sections
Hematology & Medical Oncology
Biography
I lead a group at the VA Boston Healthcare System and Harvard Medical School that uses VA clinical, genomic, and imaging data, together with machine learning and statistical methods, in research to improve patient care. We are also working on software and methodological improvements to support these efforts.
Education
Computer Science, PhD, University of Wisconsin Madison
Computer Science, MS, University of Wisconsin Madison
Philosophy/Classical Studies, BA, Carleton College
Publications
Zheng C, Khan A, Ritter D, Marks DS, Do NV, Fillmore NR, Sander C. Pancreatic cancer risk prediction using deep sequential modeling of longitudinal diagnostic and medication records. Cell Rep Med. 2025 Sep 16; 6(9):102359. PMID: 40961920.
Published on 8/7/2025Culnan JM, Goryachev SD, Bihn JR, Lee G, Chen DCR, Soloviev O, Zwolinski R, Dulberger KN, Do NV, Paller CJ, Cooperberg MR, Fillmore NR. Automated Extraction of Imaging and Pathology Data From Diverse Prostate Cancer Electronic Records. JCO Clin Cancer Inform. 2025 Aug; 9:e2500085. PMID: 40773714.
Published on 8/5/2025Jafari O, Ma S, Lam BD, Jiang JY, Zhou E, Ranjan M, Ryu J, Bandyo R, Maghsoudi A, Peng B, Amos CI, Oluyomi A, Fillmore NR, La J, Li A. Development and validation of venous thromboembolism-bidirectional encoder representations from transformers (VTE-BERT) natural language processing model. J Thromb Haemost. 2025 Aug 05. PMID: 40754035.
Published on 7/16/2025Lotfollahzadeh S, Jose A, Yang X, Bathla T, Lazowski A, Hoekstra I, Sethuraman K, Potluri S, Dulberger K, La J, Fillmore N, Piqueras MDC, Lee N, Cabral HJ, Ravid K, Chitalia V. Dietary Tryptophan Augments Cancer-Associated Venous Thrombosis Mitigated by Indoleamine 2,3-Dioxygenase 1 Inhibition. Blood Adv. 2025 Jul 16. PMID: 40668615.
Published on 6/7/2025Kim DY, Huhmann L, Hippe DS, Wheless L, Pavlis M, Hwang JC, Brophy MT, Do NV, Nghiem P, Fillmore N, Hartman RI. Treatment and disease-specific survival differences among veterans with Merkel cell carcinoma. J Am Acad Dermatol. 2025 Oct; 93(4):1103-1106. PMID: 40490100.
Published on 6/1/2025Moncayo AK, Ferguson JM, Dizon MP, Huhmann L, Kim DY, Do N, Brophy MT, Osborne TF, Spence AC, Fillmore NR, Swetter SM, Hartman RI. Area Deprivation Index and Melanoma Thickness in Veterans. JAMA Dermatol. 2025 Jun 01; 161(6):582-588. PMID: 40047783.
Published on 4/8/2025Lee MH, La J, Brophy MT, Do NV, Edwards CV, DuMontier C, Hobbs GS, Fillmore NR. Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia. Blood Adv. 2025 Apr 08; 9(7):1555-1558. PMID: 39715463.
Published on 4/1/2025Larsen JR, Zheng C, La J, Wu JT, Kelley M, Gaziano JM, Brophy M, Do NV, Kim DH, Driver JA, DuMontier C, Fillmore NR. Multimorbidity and Its Impact in Older U.S. Veterans Newly Treated for Advanced Non-Small Cell Lung Cancer. Ann Am Thorac Soc. 2025 Apr; 22(4):598-608. PMID: 39680869.
Published on 2/21/2025Swinnerton K, Fillmore NR, Vo A, La J, Elbers D, Brophy M, Do NV, Monach PA, Branch-Elliman W. Leveraging near-real-time patient and population data to incorporate fluctuating risk of severe COVID-19: development and prospective validation of a personalised risk prediction tool. EClinicalMedicine. 2025 Mar; 81:103114. PMID: 40070694.
Published on 2/3/2025Kim RB, Ryu JH, Guffey D, Zhou E, Ranjan M, Ma S, La J, Fillmore NR, Li A. Incidence and risk of arterial thromboembolism in cancer patients from a safety-net healthcare system. J Thromb Haemost. 2025 May; 23(5):1539-1550. PMID: 39909143.